Lectures, Symposia & Panels
Special Lectures
＊Special Lectures will be given at the Opening Ceremony on September 2, 2012.
Special Lectures 1
September 2 (Sun), 2012
Her Imperial Highness Princess Akiko of Mikasa
H.I.H. Princess Akiko of Mikasa is a member of the Imperial Family of Japan and the eldest daughter of H.I.H. Prince Tomohito of Mikasa. |
Japanese Art: Untold Stories
Special Lectures 2
September 2 (Sun), 2012
Teruo Okano, PhD
Institute of Advanced Biomedical and Science (TWIns)
Tokyo Women’s Medical University
Teruo Okano is currently the Professor and Director of the Institute of Advanced Biomedical Engineering and Science (ABMES) at Tokyo Women’s Medical University (TWMU) in Tokyo Japan, President of the Japanese Society for Regenerative Medicine, President of the Japan Society of Drug Delivery System and Acting Secretary General, Office of Medical Innovation, Cabinet Secretariat, Goverment of Japan. He is the author or co-author of more than 600 peer-reviewed journal articles as well as over 250 books and bookchapters. He received the Outstanding Paper Award (1990, 1995, and 1996), given by the Controlled Release Society, and the Award of the Japanese Society for Biomaterials in 1992; the Outstanding Pharmaceutical Paper Award (1997) from the Controlled Release Society and the Clemson Award for Basic Research (1997) given by the Society for Biomaterials (U.S.A). More recently, he has also received Award of the Society Polymer Science, Japan (1998), the FoundersAward (2000) from the Controlled Release Society, Leona Esaki Prize (2005) and Nagagi Innovation Award from Controlled Release Society (2006). The latest additions are the Commendation for Science and Technology by the Minister of Education, Culture, Sports, Science and Technology (2009) and Emperor’s Medal with Purple Ribbon (National Meritorious Achievement Award)(2009). |
From Concept to Clinical of Cell Sheet Tissue Engineering
We have developed a new approach that uses cultured cell layers grafted from the temperature-responsive polymer poly(N -isopropyl acylamide) that allows controlled attachment and detachment of living cells via simple temperature change maintaining both cell membrane structure and functions. Using these cultured cell sheets harvested from the temperature-responsive surfaces, we have established so called "cell sheet engineering" to create functional cell sheets to treat a wide range of diseases from corneal dysfunction to esophageal cancer, tracheal resection, and cardiac failure. For example, to overcome the limits of conventional treatments for corneal surface dysfunction, oral mucosal cells expanded ex vivo have been used as an alternative approach.
Keynote Lectures (Tentative)
Keynote lecture 1
September 3 (Mon), 2012
Takehiko Ohura, MD, PhD
Honorary President of WUWHS2012
Prof. Emeritus of Hokkaido Univ.
Pressure Ulcer & WHR Center, Kojin-kai
Dr. Ohura received a medical degree from Hokkaido University, Japan. Presently he is Professor Emeritus of Plastic Surgery at Hokkaido University and President of Pressure Ulcer and Wound Healing Research Center(Kojin-kai). |
To clarify the causes of deformation and alteration of wounds in pressure ulcer from the view of shear force and pressure
1. The act of repositioning a patient’s body and other care of the pressure ulcer, even the act of changing diapers, are all causes of wound alteration and deformities, such as undermining, step formation and also the deep narrow pressure ulcer like fissures.
Accordingly, nurses or caregivers may unknowingly make wounds worse by inadequate repositioning the patient or providing daily care which was previously thought to help make the patients better but in actuality does not.
2. Through the keen observation and attention, deformed and altered wounds teach us what kind of external forces have been applied and also how these forces have put a load on the wound in detail.
That is, how the wound surface changes clearly reflect past ulcer treatment and care. I would like to elaborate on these mechanisms and the relationships between them also highlighting methods of how we can make improvements.
Keynote lecture 2
September 3(Mon), 2012
Barbara J. Braden, PhD, RN, FAAN
Dr. Braden is Dean Emerita of the Graduate School (1995-2006) and University College (2002-2011) at Creighton University in Omaha, NE, having retired in July, 2011 after 37 years of service. She received her bachelor's from Creighton University in 1973, her master’s from University of California at San Francisco in 1975 and her Ph.D. from The University of Texas at Austin in 1988. Dr. Braden is best known for developing the Braden Scale for Predicting Pressure Sore Risk which is used in health care settings around the world and has been translated into many languages. She has received many awards for her work, including lifetime achievement awards from the National Pressure Ulcer Advisory Panel, the European Pressure Ulcer Advisory Panel and the World Union of Wound Healing Societies. |
The Braden Scale as a Global Tool
The Braden Scale is used in many countries around the world. The predictive validity of the Braden Scale has been tested in a variety of settings and populations and some of these studies will be reviewed and summarized. Various types of statistical modeling have been performed using the subscales in an attempt to determine the most parsimonious model for predicting pressure ulcer risk in various populations and these studies will be explored and summarized. The data summaries will be organized by country. The literature review will not be exhaustive due to limitations of time and the large number of studies that have been done, but will attempt to represent a sampling of geographically diverse countries and their experience in using and studying the Braden Scale.
Keynote lecture 3
September 5 (Wed), 2012
Mr. Hirotada Ototake
in preparation
Invited Lectures
in preparation
Satellite Symposia (Platinum-level Sponsors)
* Titles and contents of Sponsored Symposia are tentative.
Satellite Symposium 1
September 3 (Mon), 2012
Innovation with Negativ5e Pressure Wound Therapy Technology
Negative Pressure Wound Therapy (NPWT) continues to evolve, due to its positive effects on healing of complex wounds. KCI (Kinetic Concepts, Inc., San Antonio, Texas, USA), the original provider of V.A.C.® Therapy, and the company that has the world’s most comprehensive experience with NPWT, will present a summary of its most current products and related therapies at this unopposed symposium at the 4th World Union of Wound Healing Congress in Yokohama, Japan.
V.A.C.®Therapy is an NPWT moist wound healing technology that has been shown to draw wound edges together, remove infectious materials, reduce edema and stimulate blood flow to the wound margins. Macro and micro cellular deformations occur that enhance cell proliferation, and augment granulation tissue formation and wound healing. Since the introduction of V.A.C.® Therapy in 1997, V.A.C.® Therapy specifically has been reported in over 600 peer-reviewed articles.
An esteemed panel of clinicians will share their experiences with the latest products and KCI technologies to treat a variety of wound types and conditions. The panel will also discuss the science and mechanism of action of NPWT, and explain the effect the technology has had on wound healing in their particular specialties, illustrating the evolution that NPWT has made since its introduction, and the impact it has had on their patient outcomes.
The latest products and therapies will be showcased at the KCI symposium, focusing on the clinical effectiveness and value provided by NPWT to the wound care community.
Satellite Symposium 2
September 3 (Mon), 2012
Reducing the human and economic cost of wounds
Reducing the human and economic wounds may be the biggest challenge that we face in wound care today. This symposium will examine how this can be done in three crucial ways. Through promoting patient well-being in enduring partnerships between all stakeholders – clinicians, organisations, industry and patients; through designing products with patient wellbeing and efficiency as their core features, through constant innovation, by testing, initiating and applying therapies that are proven to reduce the human and economic cost of wounds. Our symposium will be chaired by an internationally recognized key opinion leader and leading experts in each of the three areas outlined above.
Satellite Symposium 3
September 3 (Mon), 2012
The Role of Technology in Wound Care
Included in the symposium will be presentations and clinical case examples that will discuss the importance of considering dressing technology when choosing the optimal wound dressing.
Presentations will include evidence to illustrate how dressing effectiveness is directly related to dressing properties and dressing function.
Case examples will show the links between Hydrofiber material properties, dressing features and patient benefits when used on a variety of acute and chronic wounds.
| Main Topics & Streams | Program at a Glance | Lectures, Symposia & Panels |
